Kenneth McMartin, PhD

Kenneth McMartin, PhD

Professor of Pharmacology, Toxicology and Neuroscience
Dr. Kenneth E. McMartin was trained in pharmacology and toxicology at the University of Iowa and then was a postdoctoral fellow at the Karolinska Institute in Stockholm, Sweden. He joined the department at LSU Health Sciences Center in 1980 and is now a full Professor. His major research interests have focused on determining the mechanisms behind the toxicity of chemicals so as to be able to develop antidotal treatments. As such, his laboratory developed the drug fomepizole, which is now considered the standard of care treatment for methanol and ethylene glycol poisonings. His current research aims to determine the mechanism of toxicity of diglycolic acid, the toxic metabolite of diethylene glycol (DEG), with a goal of finding treatments for late diagnosed DEG poisonings. Thus, he is considered the world’s top research expert in the toxicity of alcohols and glycols. Since he has been in Shreveport, his laboratory has been continually funded for his research through a variety of sources, including NIH, FDA, DOD, various foundations, and industrial contracts. He has received numerous awards including the Kenneth Morgareidge Award in Toxicology, Fellowship in the American Academy Clinical Toxicology (AACT), the Society of Toxicology Translational Impact Award and the Distinguished Service Award from AACT. He has mentored 8 Ph.D. students, 6 M.S. students and 6 postdoctoral researchers. In addition, he is actively involved in the training of the next generation of biomedical researchers by directing research internship programs for high school and undergraduate students.